# |
PMID |
Sentence |
1 |
18466760
|
Increase of insulin sensitivity and reversal of age-dependent glucose intolerance with inhibition of ASIC3.
|
2 |
18466760
|
ASIC3(-/-) mice were protected against age-dependent glucose intolerance with enhanced insulin sensitivity.
|
3 |
18466760
|
Acute administration of ASIC3-selective blocker APETx2 improved the glucose control and increased the insulin sensitivity in older (25-27 weeks) ASIC3(+/+) mice.
|
4 |
18466760
|
Moreover, the enhanced glucose control in aging ASIC3(-/-) mice was associated with high baseline levels of Akt phosphorylation and high copy number of mitochondrial DNA in adipose tissues.
|
5 |
18466760
|
Taken together, our data suggest that ASIC3 signaling might be involved in the control of age-dependent glucose intolerance and insulin resistance.
|
6 |
18466760
|
Increase of insulin sensitivity and reversal of age-dependent glucose intolerance with inhibition of ASIC3.
|
7 |
18466760
|
ASIC3(-/-) mice were protected against age-dependent glucose intolerance with enhanced insulin sensitivity.
|
8 |
18466760
|
Acute administration of ASIC3-selective blocker APETx2 improved the glucose control and increased the insulin sensitivity in older (25-27 weeks) ASIC3(+/+) mice.
|
9 |
18466760
|
Moreover, the enhanced glucose control in aging ASIC3(-/-) mice was associated with high baseline levels of Akt phosphorylation and high copy number of mitochondrial DNA in adipose tissues.
|
10 |
18466760
|
Taken together, our data suggest that ASIC3 signaling might be involved in the control of age-dependent glucose intolerance and insulin resistance.
|
11 |
18466760
|
Increase of insulin sensitivity and reversal of age-dependent glucose intolerance with inhibition of ASIC3.
|
12 |
18466760
|
ASIC3(-/-) mice were protected against age-dependent glucose intolerance with enhanced insulin sensitivity.
|
13 |
18466760
|
Acute administration of ASIC3-selective blocker APETx2 improved the glucose control and increased the insulin sensitivity in older (25-27 weeks) ASIC3(+/+) mice.
|
14 |
18466760
|
Moreover, the enhanced glucose control in aging ASIC3(-/-) mice was associated with high baseline levels of Akt phosphorylation and high copy number of mitochondrial DNA in adipose tissues.
|
15 |
18466760
|
Taken together, our data suggest that ASIC3 signaling might be involved in the control of age-dependent glucose intolerance and insulin resistance.
|
16 |
18466760
|
Increase of insulin sensitivity and reversal of age-dependent glucose intolerance with inhibition of ASIC3.
|
17 |
18466760
|
ASIC3(-/-) mice were protected against age-dependent glucose intolerance with enhanced insulin sensitivity.
|
18 |
18466760
|
Acute administration of ASIC3-selective blocker APETx2 improved the glucose control and increased the insulin sensitivity in older (25-27 weeks) ASIC3(+/+) mice.
|
19 |
18466760
|
Moreover, the enhanced glucose control in aging ASIC3(-/-) mice was associated with high baseline levels of Akt phosphorylation and high copy number of mitochondrial DNA in adipose tissues.
|
20 |
18466760
|
Taken together, our data suggest that ASIC3 signaling might be involved in the control of age-dependent glucose intolerance and insulin resistance.
|
21 |
18466760
|
Increase of insulin sensitivity and reversal of age-dependent glucose intolerance with inhibition of ASIC3.
|
22 |
18466760
|
ASIC3(-/-) mice were protected against age-dependent glucose intolerance with enhanced insulin sensitivity.
|
23 |
18466760
|
Acute administration of ASIC3-selective blocker APETx2 improved the glucose control and increased the insulin sensitivity in older (25-27 weeks) ASIC3(+/+) mice.
|
24 |
18466760
|
Moreover, the enhanced glucose control in aging ASIC3(-/-) mice was associated with high baseline levels of Akt phosphorylation and high copy number of mitochondrial DNA in adipose tissues.
|
25 |
18466760
|
Taken together, our data suggest that ASIC3 signaling might be involved in the control of age-dependent glucose intolerance and insulin resistance.
|
26 |
23723009
|
Multiple molecular sites of ASICs are distinctly affected in T1D, probably due to particular steric constraints for glycans accessibility to the active site: (i) ASIC1 current inactivates faster, while ASIC2 is slower; (ii) PcTx1 partly reverts diabetes effects against ASIC1- and ASIC2-inactivations; (iii) APETx2 maintains unaltered potency against ASIC3 current amplitude, but slows ASIC3 inactivation.
|
27 |
23723009
|
Immunofluorescence indicates opposite regulation of different ASIC transcripts while qRT-PCR shows that ASIC mRNA ranking (ASIC2 > ASIC1 > ASIC3) remains unaltered.
|